Purpose: To determine pressure-flow characteristics at physiologic flo
w rates in vitro and in vivo in rabbits for Ahmed, Baerveldt, Krupin d
isk, and OptiMed glaucoma implants. The Molteno dual-chamber implant a
lso was evaluated in vivo only. Methods: Five samples of each glaucoma
implant were studied. Baerveldt implants were ligated partially for i
n vitro testing. Opening and closing pressures in air or after immersi
on in balanced salt solution or plasma were evaluated for the valved d
evices (Ahmed and Krupin). Pressures were measured in vitro and in viv
o in normal rabbits at flow rates preset at between 2 and 25 mu l/minu
te after the tubes were connected to a closed manometric system. In vi
vo measurements were made 24 hours after implantation. Resistance to f
low was calculated using Poiseuille's equation after at least three se
parate flow rate readings.Results: In air, the Ahmed and Krupin valves
had opening pressures of 9.2 +/- 3.4 and 7.2 +/- 0.6 mmHg and closing
pressures of 5.2 +/- 0.9 and 3.9 +/- 1 mmHg, respectively. Neither op
ening nor closing pressures could be determined when Ahmed and Krupin
valves were immersed. In vitro, the Ahmed and OptiMed devices had high
er pressures than did other devices at a 2-mu l/minute flow rate of ba
lanced salt solution. During perfusion with plasma, only the OptiMed d
evice maintained higher pressures than with balanced salt. With all de
vices, pressures fell rapidly to zero after flow was stopped. The Opti
Med device demonstrated the highest resistance values. In vivo, the Ah
med device provided pressures of 7.5 +/- 0.8 mmHg and the OptiMed devi
ce gave pressures of 19.6 +/- 5.6 mmHg at a 2-mu l/minute flow rate. A
fter 15 minutes of flow shutdown, the OptiMed implant maintained press
ures of 7.1 +/- 1.1 mmHg. The Baerveldt (nonligatured), Krupin, and Mo
lteno dual-chamber implants had similar resistances and pressures in v
ivo. Pressures with all devices in vivo fell rapidly to zero after con
junctival wound disruption. Conclusion: Neither the Ahmed nor Krupin d
evices had demonstrable opening or closing pressures when tested in vi
tro immersed in balanced salt solution or plasma. With all devices, pr
essures were higher in vivo than in vitro due to tissue-induced resist
ance around the explant. Both Ahmed and Krupin valves functioned as fl
ow-restricting devices at the flow rates studied, but did not close af
ter initial perfusion with fluid.